X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.76
Delayed Data
As of Jun 22
 +0.02 / +1.15%
Today’s Change
1.55
Today|||52-Week Range
4.14
-23.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses466.4K196.1K298.2K201.7K
 
 
 
 
 
Research And Development15.8K9.3K--11.2K
 
 
 
 
Total Operating Expenses466.4K196.1K298.2K201.7K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-466.4K-196.1K-294.1K-201.7K
 
 
 
 
 
Interest Expense On Debt0.000.000.006.1K
 
 
Other Expenses-1.0M1.3M16.5K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.5M1.6M-2.1K891.5K
 
 
 
 
 
Net Income-1.5M1.6M-2.1K891.5K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.1M5.1M5.1M5.1M
 
 
 
 
 
Shares To Calculate EPS Diluted5.1M5.1M5.1M5.1M
 
 
 
 
 
 
Earnings Per ShareEPS------$0.20
 
 
EPS Diluted-$0.32$0.31-$0.00$0.20